Location
France, Europe
Check Size
$2M - $10M
Investment Stage
Seed
Series A
Series B
Focus Areas
Health IT
Digital Health
BioTech
Consumer Health
Medical Devices
About Investor
Jean-Christophe Renondin serves as Managing Partner at Vesalius Biocapital IV, a Luxembourg-based life sciences venture capital investor. The firm focuses on BioTech, Medical Devices, Digital Health, Health IT, and Consumer Health investments at Seed, Series A, and Series B stages, with investment ranges from €2,000,000 to €10,000,000. Vesalius Biocapital IV invests in later-stage companies in drug development, medical devices & diagnostics, and eHealth/mHealth predominantly in Europe.
Similar Investors
CJ
Christoph Janz
Germany, Europe
$580K - $3.5M
Pre Seed
,Seed
,IT
Igor Tikhturov
United Kingdom, Europe
$100K - $5M
Pre Seed
,Seed
,PL
Pierre-Eric Leibovici
France, Europe
$500K - $10M
Seed
,Series A
,JB
Joe Bond
United Kingdom, Europe
$500K - $2M
Seed
,ER
Elliot Richmond
United Kingdom, Europe
$1M - $5M
Pre Seed
,Seed
,GW
Ginny Watsham
United Kingdom, Europe
$100K - $5M
Seed
,Series A
,Is this Your Profile?
If you have any updates, please fill out our form.